N4 Pharma (LON:N4P) Trading 18.2% Higher – Here’s Why

N4 Pharma Plc (LON:N4P)’s share price was up 18.2% on Thursday . The company traded as high as GBX 0.65 ($0.01) and last traded at GBX 0.65 ($0.01). Approximately 321,732 shares changed hands during mid-day trading, a decline of 73% from the average daily volume of 1,185,063 shares. The stock had previously closed at GBX 0.55 ($0.01).

N4 Pharma Price Performance

The firm’s 50 day simple moving average is GBX 0.64 and its 200-day simple moving average is GBX 0.57. The company has a current ratio of 22.73, a quick ratio of 7.28 and a debt-to-equity ratio of 1.62. The stock has a market capitalization of £2.37 million, a price-to-earnings ratio of -55.00 and a beta of -0.37.

N4 Pharma Company Profile

N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.